TORONTO, Ontario, Feb. 2 -- The Journal of Rheumatology, a peer-reviewed journal from the Canadian Rheumatology Association that says it features the discovery of therapeutic targets in the treatment of rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis and other rheumatic and musculoskeletal diseases, published research articles on the following topics in its February 2024 edition (Vol. 51, Issue 2):

Editorials: